Renin-angiotensin-aldosterone system (RAAS) inhibitor, Clinofibrate, Purity ≥98%

Synonym: 30299-08-2; Lipoclin; S-8527; Butanoic acid, 2,2'-[cyclohexylidenebis(4,1-phenyleneoxy)]bis[2-methyl-; 2-[4-[1-[4-(2-Carboxybutan-2-yloxy)phenyl]cyclohexyl]phenoxy]-2-methylbutanoic acid; 2-[4-[1-[4-(2-Carboxybutan-2-yloxy)phenyl]cyclohexyl]phenoxy]-2-methylbutanoic acid; Renin-angiotensin-aldosterone system (RAAS) inhibitor

MDL: MFCD00865769
CAS Number: 30299-08-2
Compound CID: 2787

Product Size

10 mg; 50 mg; 100 mg; 200 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Clinofibrate, soluble in DMSO and ethanol and insoluble in water, is an effective cell metabolism inhibitor, that has the ability to prevent the pathway of HMG-CoA reductase by inhibiting endocrinology-hormones. The molecular weight of the compound is 468.58, and its molecular formula is C₂₈H₃₆O₆. It targets the HMGCR.

Molecular Weight

468.58

Molecular Formula

C₂₈H₃₆O₆

Targets

HMGCR

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 90 mg/mL (192.06 mM); Water: insoluble; Ethanol: 90 mg/mL (192.06 mM)

Identity

Confirmed by NMR/HPLC/MS.

Applications

Clinofibrate plays a key role in enhancing lipid metabolism and reducing the risk of cardiovascular diseases.